Human trials employing standardized extracts (e.g., SHR-5) at doses ranging from 200 to 680 mg/day have reported a low incidence of adverse events, primarily mild and transient symptoms such as dizziness, dry mouth, or gastrointestinal discomfort
For context, the GHK-Cu copper peptide another compound with a strong preclinical profile faces similar evidence constraints
If results are promising, the programme moves to Phase 3: larger, global, randomised trials involving, dependent on the indication hundreds to sometimes even thousands of participants, designed to confirm efficacy and build a robust safety profile
injection is a shot given in large muscle groups, typically shoulder (deltoid), thigh (vastus lateralis) and/or butt (gluteus)
Take 1 capsule twice daily, at least 1 hour before or after eating or drinking anything other than water